首页> 外文期刊>Experimental and clinical transplantation >Histologic Evaluations of Xenotransplanted Rabbit Knees by In Vitro-Propagated Human Amniotic Epithelial Cells: A Preclinical Study
【24h】

Histologic Evaluations of Xenotransplanted Rabbit Knees by In Vitro-Propagated Human Amniotic Epithelial Cells: A Preclinical Study

机译:通过体外繁殖的人羊膜上皮细胞组织学评价Xenotroansplated兔膝关节:临床前研究

获取原文
           

摘要

Objectives: Human amniotic epithelial cells have multipotent differentiation capacity and are consi?-dered as potential therapeutic cells for clinical use. This study represents the first published report on the evaluation of the safety and clinical feasibility of human amniotic epithelial cells for transplant into knee joints, serving as an initial step for subsequent therapeutic evaluations within arthritis clinics. Materials and Methods: Our experimental design was based on subjecting groups of rabbits as a recipient model for human amniotic epithelial cell transplant into knee joints. Twenty rabbits received 200 ?μL sterile 0.9% sodium chloride solution containing 1 ?- 109 human amniotic epithelial cells/knee joint by intra-articular injection. Control groups received cell-free saline into knees, and some animals were not treated. After 10 days of xenotransplant, radiology scans and histologic sections of transplanted and nontrans?-planted knees were examined and compared. Immunohistochemistry staining was also applied to detect tumor necrosis factor-alpha and interleukin 17 (as inflammatory and immuno-rejection markers) in knee sections. Results: Similar to results shown in noninjected and saline-injected knees, all treated knees appeared normal, with no signs of acute immuno-rejection, no microbial colonization, no pain, no allergic reactions, no inflammation, and normal motion. Use of human amniotic epithelial cells appeared safe without risk of immuno-rejection or tumor formation in the transplanted knee joint. Conclusions: Human amniotic epithelial cells can be safely transplanted into knee joints, encouraging a need for complementary research for further therapeutic evaluations of human amniotic epithelial cells for curing arthritis.
机译:目的:人羊膜上皮细胞具有多能分化能力,并作为临床用途的潜在治疗细胞。本研究代表了第一次公布关于评估人羊膜上皮细胞的安全性和临床可行性的发表报告,用于移植到膝关节中的膝关节,作为关节炎诊所内随后治疗评价的初步步骤。材料和方法:我们的实验设计基于兔子的受体组,作为人羊膜上皮细胞移植到膝关节中的受体模型。 20个兔子接受含有1〜109人羊膜上皮细胞/膝关节的含有1〜109人羊膜细胞/膝关节的兔子。对照组将无细胞盐水接受膝关节,并且一些动物未被处理。经过10天的异种蛋白,检测和非截止膝关节的放射学扫描和组织学区进行检查并进行比较。免疫组织化学染色也施用以检测膝关节切片中的肿瘤坏死因子-α和白细胞介素17(作为炎症和免疫排斥标志物)。结果:类似于非灭虫和盐水注入膝盖所示的结果,所有处理的膝盖都呈现正常,没有急性免疫排斥,无微生物定植,无疼痛,没有过敏反应,无炎症,正常运动。使用人羊膜上皮细胞出现了安全的,没有在移植的膝关节中的免疫排斥或肿瘤形成的风险。结论:人羊膜上皮细胞可以安全地移植到膝关节中,令人抱怨对人羊膜炎治疗关节炎的进一步治疗评估的互补研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号